Opinion statement
Depending on patient and tumor characteristics, reported 5-year actuarial survival rates of patients with cervical nodal metastasis from an unknown primary carcinoma range from 18% to 63%. Prognostic factors for survival include N-stage, number of nodes, grading, extracapsular extension, and performance status. Retrospective studies suggest that neck relapse is more common than are distant metastases or emergence of mucosal primary tumors. The treatment options include neck dissection alone, radiation alone to the neck with or without the putative mucosal origin, and combination unilateral neck dissection plus limited or comprehensive radiotherapy. Combination of nodal dissection with comprehensive bilateral radiotherapy yielded most favorable results in localregional disease control. However, its impact on the quality of life should be recognized. Also, the confounding effects of patient selection for various treatment modalities on therapeutic outcome cannot be quantified. Retrospective single-institution comparisons between comprehensive and unilateral neck radiotherapy did not show apparent differences in outcome. A randomized trial to compare the therapeutic value of comprehensive versus volume-limited radiotherapy is being planned. No data were found to support the benefit of chemotherapy for the treatment of this disease.
Similar content being viewed by others
References and Recommended Reading
Sinnathamby K, Peters LJ, Laidlaw C, Hughes PG: The occult head and neck primary: to treat or not to treat? Clin Oncol 1997, 9:322–329.
Grau C, Johansen LV, Jakobsen J, et al.: Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology. Radiother Oncol 2000, 55:121–129. A comprehensive national survey of treatment results with different therapeutic strategies.
DeBraud F, Al-Sarraf M: Diagnosis and management of squamous cell carcinoma of unknown primary tumor site of the neck. Semin Oncol 1993, 20:273–278.
Nieder C, Gregoire V, Ang KK: Cervical lymph node metastases from occult squamous cell carcinoma: cut down a tree to get an apple? Int J Radiat Oncol Biol Phys 2001, 50:727–733. A review of both current diagnostic strategies, including positron emission tomography, fluorescence-guided biopsy, and molecular diagnostics and therapeutic options.
Kulapaditharom B, Boonkitticharoen V, Kunachak S: Fluorescence-guided biopsy in the diagnosis of an unknown primary cancer in patients with metastatic cervical lymph nodes. Ann Otol Rhinol Laryngol 1999, 108:700–704.
Lee WY, Hsiao JR, Jin YT, Tsai ST: Epstein-Barr virus detection in neck metastases by in-situ hybridization in fine-needle aspiration cytologic studies: an aid differentiating the primary site. Head Neck 2000, 22:336–340.
McGuirt WF: The neck mass. Med Clin North Am 1999, 83:219–234.
Reddy SP, Marks JE: Metastatic carcinoma in the cervical lymph nodes from an unknown primary site: results of bilateral neck plus mucosal irradiation vs. ipsilateral neck irradiation. Int J Radiat Oncol Biol Phys 1997, 37:797–802.
Fernandez JA, Suarez C, Martinez JA, et al.: Metastatic squamous cell carcinoma in cervical lymph nodes from an unknown primary tumor: prognostic factors. Clin Otolaryngol 1998, 23:158–163.
Colletier PJ, Garden AS, Morrison WH, et al.: Postoperative radiation for squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: outcomes and patterns of failure. Head Neck 1998, 20:674–681.
Glynne-Jones RG, Anand AK, Young TE, Berry RJ: Metastatic carcinoma in the cervical lymph nodes from an occult primary: a conservative approach to the role of radiotherapy. Int J Radiat Oncol Biol Phys 1990, 18:289–294.
de Braud F, Heilbrun LK, Ahmed K, et al.: Metastatic squamous cell carcinoma of an unknown primary localized to the neck. Advantages of an aggressive treatment. Cancer 1989, 64:510–515.
Kirschner MJ, Fietkau R, Waldfahrer F, et al.: Therapy of cervical lymph metastases of unknown primary tumor. [German]. Strahlenther Onkol 1997, 173:362–368.
Anderson WF, Hawk E, Berg CD: Secondary chemoprevention of upper aerodigestive tract tumors. Semin Oncol 2001, 28:106–120.
Coker DD, Casterline PF, Chamber RG, Jaques DA: Metastases to lymph nodes of the head and neck from an unknown primary site. Am J Surg 1977, 134:517–522.
Coster JR, Foote RL, Olsen KD, et al.: Cervical nodal metastasis of squamous cell carcinoma of unknown origin: indications for withholding radiation therapy. Int J Radiat Oncol Biol Phys 1992, 23:743–749.
Wang RC, Goepfert H, Barber AE, Wolf P: Unknown primary squamous cell carcinoma metastatic to the neck. Arch Otolaryngol Head Neck Surg 1990, 116:1388–1393.
Erkal HS, Mendenhall WM, Amdur RJ, et al.: Squamous cell carcinomas metastatic to cervical lymph nodes from an unknown head-and-neck mucosal site treated with radiation therapy alone or in combination with neck dissection. Int J Radiat Oncol Biol Phys 2001, 50:55–63.
Jones AG, Cook JA, Phillips DE, Roland NR: Squamous carcinoma presenting as an enlarged cervical lymph node. Cancer 1993, 72:1756–1761.
Weir L, Keane T, Cummings B, et al.: Radiation treatment of cervical lymph node metastases from an unknown primary: an analysis of outcome by treatment volume and other prognostic factors. Radiother Oncol 1995, 35:206–211.
Strojan P, Anicin A: Combined surgery and postoperative radiotherapy for cervical lymph node metastases from an unknown primary tumour. Radiother Oncol 1998, 49:33–40.
Medini E, Medini AM, Lee CK, et al.: The management of metastatic squamous cell carcinoma in cervical lymph nodes from an unknown primary. Am J Clin Oncol 1998, 21:121–125.
Bataini JP, Rodriguez J, Jaulerry C, et al.: Treatment of metastatic neck nodes secondary to an occult epidermoid carcinoma of the head and neck. Laryngoscope 1987, 97:1080–1084.
Lefebvre JL, Coche-Dequeant B, Van JT, et al.: Cervical lymph nodes from an unknown primary tumor in 190 patients. Am J Surg 1990, 160:443–446.
Maulard C, Housset M, Brunel P, et al.: Postoperative radiation therapy for cervical lymph node metastases from an occult squamous cell carcinoma. Laryngoscope 1992, 102:884–890.
Davidson BJ, Spiro RH, Patel S, et al.: Cervical metastases of occult origin: the impact of combined modality therapy. Am J Surg 1994, 168:395–399.
Nguyen C, Shenouda G, Black MJ, et al.: Metastatic squamous cell carcinoma to cervical lymph nodes from unknown primary mucosal sites. Head Neck 1994, 16:58–63.
Harper CS, Mendenhall WM, Parsons JT, et al.: Cancer in neck nodes with unknown primary site: role of mucosal radiotherapy. Head Neck 1990, 12:463–469.
Marcial-Vega VA, Cardenes H, Perez CA, et al.: Cervical metastases from unknown primaries: radiotherapeutic management and appearance of subsequent primaries. Int J Radiat Oncol Biol Phys 1990, 19:919–928.
Fu KK, Pajak TF, Trotti A, et al.: A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000, 48:7–16. This randomized trial compares the effectiveness of four different fractionation schedules in head and neck radiotherapy.
Owen JB, Grigsby PW, Caldwell TM, et al.: Can costs be measured and predicted by modeling within a cooperative clinical trials group? Economic methodologic pilot studies of the RTOG studies 90-03 and 91-04. Int J Radiat Oncol Biol Phys 2001, 49:633–639.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nieder, C., Ang, K.K. Cervical lymph node metastases from occult squamous cell carcinoma. Curr. Treat. Options in Oncol. 3, 33–40 (2002). https://doi.org/10.1007/s11864-002-0039-7
Issue Date:
DOI: https://doi.org/10.1007/s11864-002-0039-7